HhAntag,
496794-70-8,
N-(4-chloro-3-(5-(dimethylamino)-1H-benzo[d]imidazol-2-yl)phenyl)-3,5-dimethoxybenzamide,
GLI1-mediated transcription inhibitor,
Stemolecule SMO Antagonist,
CHEMBL516246,
N-(4-chloro-3-(6-(dimethylamino)-1H-benzo[d]imidazol-2-yl)phenyl)-3,5-dimethoxybenzamide,
SCHEMBL2157955,
DTXSID90432730,
EX-A812,
BCP21219,
BDBM50249520,
MFCD27918645,
ZINC40917821,
AKOS032961100,
CS-1233,
NCGC00378698-01,
AK174130,
HY-15412,
J3.506.077D,
A12418,
W-6093,
Benzamide, N-[4-chloro-3-[6-(dimethylamino)-1H-benzimidazol-2-yl]phenyl]-3,5-dimethoxy-,
N-[4-chloro-3-[6-(dimethylamino)-1H-benzimidazol-2-yl]phenyl]-3,5-dimethoxybenzamide,
CID9911630,
A3460,
N-[4-chloro-3-(6-dimethylamino-1H-benzoimidazol-2-yl)phenyl]-3,5-dimethoxy-benzamide,